December 7, 2021
AdvanTx would like to distribute two external corporate collaboration opportunities for faculty - The Johnson and Johnson Quickfire Challenge for immune-mediated diseases and a Beta-Propellor Proteins Discovery Opportunity.
November 17, 2021
UNC-Chapel Hill and UC San Francisco scientists have published work in Nature, laying the groundwork for better anti-itching medications with fewer side effects. The work was led by UNC School of Medicine scientists Bryan L. Roth, MD, PhD, Jonathan Fay, PhD, and Can Cao, PhD.
October 18, 2021
This new method, created by the UNC School of Medicine labs of Klaus Hahn and Tim Elston, has the potential to super-charge the study of human proteins as they interact and change their conformations in fundamentally important ways in human health and disease.
April 28, 2021
UNC's NC TraCS and the Center for Advanced Self-powered Systems of Integrated Sensors and Technologies (ASSIST) at NC State is seeking highly innovative proposals that address high-impact unmet clinical needs using NC State’s ASSIST-developed technologies. The goal of this Special Emphasis is to match UNC providers’ expertise of clinical challenges and unmet needs, with engineering faculty at ASSIST seeking to develop novel technology applications.
April 28, 2021
The Graduate School has named Juanita Limas, PhD candidate in the Department of Pharmacology, as the 2021 recipient of the Boka W. Hadzija Award for Distinguished University Service.
March 18, 2021
Researchers in the UNC School of Medicine Lab of Thomas Kash, PhD, published new findings in the journal Neuron showing how neurons in two brain regions use dopamine to promote pain responses differently in male and female mice.
November 7, 2019
The Innovator Awards recognize Association of Community Cancer Center member programs for their ingenuity and pioneering achievements in oncology. Innovations advance the goals of improving access, quality, and value in cancer care delivery.
April 4, 2018
Scientists led by Rob Nicholas, PhD, at the UNC School of Medicine show how the gonorrhea bacterium resists last-resort antibiotic ceftriaxone while maintaining a robust growth rate.